Chiesi’s abstract presentations will focus on clinical insights and patient-reported outcomes inFabry disease and alpha-mannosidosis ---- ...

Abstract accepted for oral scientific presentation at the 2011 annual meeting of the American Roentgen Ray Society, Chicago, IL. May 1-6, 2011. Morgan DE, Patel B, Thomas J, Lockhart M. Dual energy ...

The ongoing global Phase 2b REZOLVE-AD study (NCT06136741) enrolled 393 patients with moderate-to-severe atopic dermatitis who had not previously received treatment with biologic or JAK inhibitor ...

NEW ORLEANS--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced the presentation of 27 abstracts at the American Association of Nephrology (ASN) ...

Daix (France), Long Island City (New York, United States), June 3, 2022 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral ...

Autonomix Medical's research on treating pancreatic cancer pain has been accepted for presentation at the SIO 2025 Annual Meeting. Autonomix Medical, Inc. has announced that its abstract has been ...

Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation ...

Opinion: Advocates engaged in litigation involving complex science must be prepared to navigate technical evidence, expert ...

Gaddikeri S, Vattoth S, DeHoff III GW, Smith CB, Combs JT, Roberson GR. Rathke Cleft Cysts: MR criteria for presumptive diagnosis. American Society of Neuroradiology ...

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo in patients who had atopic dermatitis and a history of asthma Extended ...